Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: Functional implications

Frontiers in Endocrinology

Volumn 3, Issue JAN, 2013, Pages

  Stengel, Andreas ^a   Taché, Yvette ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cortistatin; Ghrelin cell; Somatostatin receptor agonists and antagonist; Somatostatin receptor subtypes; X A like cell

Indexed keywords

EID: 84874264433     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00178     Document Type: Review

References (170)

1. Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., et al. (2001). Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 86, 4753-4758.
2. Banks, W. A., Tschöp, M., Robinson, S. M., and Heiman, M. L. (2002). Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J. Pharmacol. Exp. Ther. 302, 822-827.
3. Baragli, A., Alturaihi, H., Watt, H. L., Abdallah, A., and Kumar, U. (2007). Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell. Signal. 19,2304-2316.
4. Barkan, A. L., Dimaraki, E. V., Jes-sup, S. K., Symons, K. V., Ermolenko, M., and Jaffe, C. A. (2003). Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J. Clin. Endocrinol. Metab. 88, 2180-2184.
5. Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., et al. (1982). SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31, 1133-1140.
6. Bertherat, J., Bluet-Pajot, M. T., and Epelbaum, J. (1995). Neuroen-docrine regulation of growth hormone. Eur. J. Endocrinol. 132, 12-24.
7. Bradette, M., Delvaux, M., Stau-mont, G., Fioramonti, J., Bueno, L., and Frexinos, J. (1994). Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig. Dis. Sci. 39,1171-1178.
8. Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., et al. (1973). Hypothalamic polypep-tide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179, 77-79.
9. Briard, N., Dutour, A., Epelbaum, J., Sauze, N., Slama, A., and Oliver, C. (1997). Species differences between male rat and ram pituitary somatostatin receptors involved in the inhibition of growth hormone secretion. Eur. I Endocrinol. 137, 545-555.
10. Broglio, F., Grottoli, S., Arvat, E., and Ghigo, E. (2008). Endocrine actions of cortistatin: in vivo studies. Mol. Cell. Endocrinol. 286, 123-127.
11. Broglio, F., Papotti, M., Muccioli, G., and Ghigo, E. (2007). Brain-gut communication: cortistatin, somatostatin and ghrelin. Trends Endocrinol. Metab. 18,246-251.
12. Broglio, F., Van Koetsveld, P., Benso, A., Gottero, C., Prodam, F., Papotti, M., et al. (2002). Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J. Clin. Endocrinol. Metab. 87, 4829-4832.
13. Brown, M. R., Rivier, C., and Vale, W. (1984). Central nervous system regulation of adreno-corticotropin secretion: role of somatostatins. Endocrinology 114, 1546-1549.
14. Cescato, R., Erchegyi, J., Waser, B., Pic-cand, V., Maecke, H. R., Rivier, J. E., et al. (2008). Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting. J. Med. Chem. 51, 4030-4037.
15. Corbetta, S., Peracchi, M., Cap-piello, V., Lania, A., Lauri, E., Vago, L., et al. (2003). Circulating ghrelin levels in patients with pancreatic and gastrointestinal neu-roendocrine tumors: identification of one pancreatic ghrelinoma. J. Clin. Endocrinol. Metab. 88, 3117-3120.
16. Cordoba-Chacon, J., Gahete, M. D., Culler, M. D., Castano, J. P., Kine-man, R. D., and Luque, R. M. (2012). Somatostatin dramatically stimulates growth hormone release from primate somatotrophs acting at low doses via somatostatin receptor 5 and cyclic AMP. J. Neuroendocrinol. 24, 453-463.
17. Cordoba-Chacon, J., Gahete, M. D., Pozo-Salas, A. I., Martinez-Fuentes, A. J., de Lecea, L., Gracia-Navarro, E, et al. (2011). Cortistatin is not a somatostatin analogue but stimulates prolactin release, and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin. Endocrinology 152, 4800-4812.
18. Corleto, V D., Severi, C., Romano, G., Tattoli, I., Weber, H. C., Strids-berg, M., et al. (2006). Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol. Motil. 18, 217-225.
19. Costa, M., Patel, Y., Furness, J. B., and Arimura, A. (1977). Evidence that some intrinsic neurons of the intestine contain somatostatin. Neurosci. Lett. 6,215-222.
20. Culler, M. D., Oberg, K., Arnold, R., Krenning, E. P., Sevilla, I., and Diaz, J. A. (2011). Somatostatin analogs for the treatment of neuroen-docrine tumors. Cancer Metastasis Rev. 30(Suppl. 1), 9-17.
21. Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., and Weigle, D. S. (2001). A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 50, 1714-1719.
22. Cummings, D. E.,Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., et al. (2002). Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346, 1623-1630.
23. Dalm, V. A., Van Hagen, P. M., de Krijger, R. R., Kros, J. M., Van Koetsveld, P. M., Van Der Lely, A. J., et al. (2004). Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues. Clin. Endocrinol. (Oxf.) 60,625-629.
24. Damian, M., Marie, J., Leyris, J. P., Fehrentz, J. A., Verdie, P., Martinez, J., et al. (2012). High constitutive activity is an intrinsic feature of ghrelin receptor protein: a study with a functional monomeric GHS-R1a receptor reconstituted in lipid discs. J. Biol. Chem. 287, 3630-3641.
25. Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Mat-suo, H., et al. (2002). The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroen-terology 123, 1120-1128.
26. Davenport, A. P., Bonner, T. I., Foord, S. M., Harmar, A. J., Neubig, R. R., Pin, J. P., et al. (2005). International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol Rev. 57, 541-546.
27. Davies, J. S., Kotokorpi, P., Eccles, S. R., Barnes, S. K., Tokarczuk, P. F., Allen, S. K., et al. (2009). Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol. Endocrinol. 23,914-924.
28. Deghenghi, R., Avallone, R., Torsello, A., Muccioli, G., Ghigo, E., and Locatelli, V (2001a). Growth hormone-inhibiting activity of cortistatin in the rat. J. Endocrinol Invest. 24, RC31-RC33.
29. Deghenghi, R., Papotti, M., Ghigo, E., and Muccioli, G. (2001b). Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J. Endocrinol Invest. 24, RC1- RC33.
30. Deghenghi, R., Papotti, M., Ghigo, E., Muccioli, G., and Locatelli, V. (2001c). Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland. Endocrine 14, 29-33.
31. de Heer, J., Rasmussen, C., Coy, D. H., and Holst, J. J. (2008). Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 51,2263-2270.
32. de la Cour, C. D., Norlen, P., and Hakanson, R. (2007). Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. Regul Pept. 143, 118-126.
33. de Lecea, L., Criado, J. R., Prospero-Garcia, O., Gautvik, K. M., Schweitzer, P., Danielson, P. E., et al. (1996). A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381, 242-245.
34. de Lecea, L., del Rio, J. A., Criado, J. R., Alcantara, S., Morales, M., Daniel-son, P. E., et al. (1997a). Cortistatin is expressed in a distinct subset of cortical interneurons. J Neurosci. 17, 5868-5880.
35. de Lecea, L., Ruiz-Lozano, P., Daniel-son, P. E., Peelle-Kirley, J., Foye, P. E., Frankel, W. N., et al. (1997b). Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. Genomics 42,499-506.
36. Di Vito, L., Broglio, F., Benso, A., Got-tero, C., Prodam, F., Papotti, M., et al. (2002). The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin. Endocrinol (Oxf.) 56, 643-648.
37. Druce, M. R., Wren, A. M., Park, A. J., Milton, J. E., Patterson, M., Frost, G., et al. (2005). Ghrelin increases food intake in obese as well as lean subjects. Int. I Obes. (Lond.) 29, 1130-1136.
38. Ekeblad, S., Lejonklou, M. H., Grim-fjard, P., Johansson, T., Eriksson, B., Grimelius, L., et al. (2007). Co-expression of ghrelin and its receptor in pancreatic endocrine tumours. Clin. Endocrinol (Oxf.) 66,115-122.
39. Erchegyi, J., Cescato, R., Grace, C. R., Waser, B., Piccand, V., Hoyer, D., et al. (2009). Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues. J. Med. Chem. 52, 2733-2746.
40. Erchegyi, J., Grace, C. R., Samant, M., Cescato, R., Piccand, V., Riek, R., et al. (2008). Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity. J. Med. Chem. 51, 2668-2675.
41. Fehlmann, D., Langenegger, D., Schuep-bach, E., Siehler, S., Feuerbach, D., and Hoyer, D. (2000). Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery. J. Physiol. Paris 94,265-281.
42. Feifel, D., and Vaccarino, F. J. (1990). Central somatostatin: a re-examination of its effects on feeding. Brain Res. 535, 189-194.
43. Feng, D. D., Yang, S. K., Loudes, C., Simon, A., Al-Sarraf, T., Culler, M., et al. (2011). Ghrelin and obestatin modulate growth hormone-releasing hormone release and synaptic inputs onto growth hormone-releasing hormone neurons. Eur. J. Neurosci. 34, 732-744.
44. Finley, J. C., Maderdrut, J. L., Roger, L. J., and Petrusz, P. (1981). The immunocytochemical localization of somatostatin-containing neurons in the rat central nervous system. Neu-roscience 6,2173-2192.
45. Fischer, T., Doll, C., Jacobs, S., Kolodziej, A., Stumm, R., and Schulz, S. (2008). Reassessment of sst2 somatostatin receptor expression in human normal and neo-plastic tissues using the novel rabbit monoclonal antibody UMB-1. J. Clin. Endocrinol Metab. 93, 4519-4524.
46. Fukusumi, S., Kitada, C., Takekawa, S., Kizawa, H., Sakamoto, J., Miyamoto, M., et al. (1997). Identification and characterization of a novel human cortistatin-like peptide. Biochem. Biophys. Res. Commun. 232, 157-163.
47. Gahete, M. D., Cordoba-Chacon, J., Duran-Prado, M., Malagon, M. M., Martinez-Fuentes, A. J., Gracia-Navarro, F., et al. (2010a). Somatostatin and its receptors from fish to mammals. Ann. N. Y. Acad. Sci. 1200, 43-52.
48. Gahete, M. D., Cordoba-Chacon, J., Salvatori, R., Castano, J. P., Kine-man, R. D., and Luque, R. M. (2010b). Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothala-mus, pituitary, and stomach. Mol. Cell Endocrinol. 317, 154-160.
49. Gardi, J., Obal, F. Jr., Fang, J., Zhang, J., and Krueger, J. M. (1999). Diurnal variations and sleep deprivation-induced changes in rat hypothalamic GHRH and somatostatin contents. Am. J. Physiol. 277, R1339-R1344.
50. Giovacchini, G., Nicolas, G., and Forrer, F. (2012). Peptide receptor radionu-clide therapy with somatostatin analogues in neuroendocrine tumors. Anticancer Agents Med. Chem. 12, 526-542.
51. Gonzalez, C. R., Vazquez, M. J., Lopez, M., andDieguez, C. (2008). Influence of chronic undernutrition and leptin on GOAT mRNA levels in rat stomach mucosa. J. Mol Endocrinol. 41, 415-421.
52. Gonzalez-Rey, E., and Delgado, M. (2008). Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders. Mol Cell Endocrinol. 286, 135-140.
53. Grace, C. R., Erchegyi, J., Koerber, S. C., Reubi, J. C., Rivier, J., and Riek, R. (2006). Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR. J. Med. Chem. 49,4487-4496.
54. Grace, C. R., Erchegyi, J., Samant, M., Cescato, R., Piccand, V., Riek, R., et al. (2008). Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity. J. Med. Chem. 51, 2676-2681.
55. Gregersen, T., Gronbaek, H., Worsoe, J., Schlageter, V., Laurberg, S., and Krogh, K. (2011). Effects of Sando-statin LAR on gastrointestinal motil-ity in patients with neuroendocrine tumors. Scand. J. Gastroenterol. 46, 895-902.
56. Guillemin, R. (2011). Neuroen-docrinology: a short historical review. Ann. N Y Acad. Sci. 1220, 1-5.
57. Gutierrez, J. A., Solenberg, P. J., Perkins, D. R., Willency, J. A., Knierman, M. D., Jin, Z., et al. (2008). Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl Acad. Sci. U.S.A. 105, 6320-6325.
58. Hotta, M., Shibasaki, T., Arai, K., and Demura, H. (1999). Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res. 823, 221-225.
59. Ishikawa, M., Mizobuchi, M., Taka-hashi, H., Bando, H., and Saito, S. (1997). Somatostatin release as measured by in vivo microdialysis: circadian variation and effect of prolonged food deprivation. Brain Res. 749,226-231.
60. Iwakura, H., Hosoda, K., Doi, R., Komoto, I., Nishimura, H., Son, C., et al. (2002). Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I. J. Clin. Endocrinol. Metab. 87, 4885-4888.
61. Iwakura, H., Li, Y., Ariyasu, H., Hosoda, H., Kanamoto, N., Bando, M., et al. (2010). Establishment of a novel ghrelin-producing cell line. Endocrinology 151, 2940-2945.
62. Jawiarczyk, A., Bolanowski, M., Syrycka, J., Bednarek-Tupikowska, G., Kaluzny, M., Kolodziejczyk, A., et al. (2012). Effective therapy of insulinoma by using long-acting somatostatin analogue. A case report and literature review. Exp. Clin. Endocrinol. Diabetes 120, 68-72.
63. Johansson, O., Hokfelt, T., and Elde, R. P. (1984). Immunohistochemi-cal distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuro-science 13,265-339.
64. Kang, K., Schmahl, J., Lee, J. M., Garcia, K., Patil, K, Chen, A., et al. (2012). Mouse ghrelin-O-acyltransferase (GOAT) plays a critical role in bile acid reabsorption. FASEB J.26,259-271.
65. Kim, M. S., Yoon, C. Y., Park, K. H., Shin, C. S., Park, K. S., Kim, S. Y., et al. (2003). Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport 14, 1317-1320.
66. Kineman, R. D., and Luque, R. M. (2007). Evidence that ghrelin is as potent as growth hormone (GH)-releasing hormone (GHRH) in releasing GH from primary pituitary cell cultures of a nonhuman primate (Papio anubis), acting through intracellular signaling pathways distinct from GHRH. Endocrinology 148,4440-4449.
67. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kan-gawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660.
68. Kojima, M., Hosoda, H., Matsuo, H., and Kangawa, K. (2001). Ghrelin: discovery of the natural endogenous ligand for the growth hormone secre-tagogue receptor. Trends Endocrinol. Metab. 12, 118-122.
69. Kojima, M., and Kangawa, K. (2005). Ghrelin: structure and function. Physiol Rev. 85, 495-522.
70. Kojima, M., and Kangawa, K. (2011). The discovery of ghrelin: with a little luck and great passion. Peptides 32, 2153-2154.
71. Kreienkamp, H. J., Akgun, E., Baumeis-ter, H., Meyerhof, W., and Richter, D. (1999). Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs. FEBS Lett. 462, 464-466.
72. Lanfranco, F., Motta, G., Baldi, M., Gasco, V., Grottoli, S., Benso, A., et al. (2010). Ghrelin and anterior pituitary function. Front. Horm. Res. 38, 206-211.
73. Lim, C. T., Kola, B., Grossman, A., and Korbonits, M. (2011). The expression of ghrelin O-acyltransferase (GOAT) in human tissues. Endocr. J. 8, 707-710.
74. Liu, Y., Zhou, Y. B., Zhang, G. G., Cai, Y., Duan, X. H., Teng, X., et al. (2010). Cortistatin attenuates vascular calcification in rats. Regul. Pept. 159,35-43.
75. Lloyd, K. C., Amirmoazzami, S., Friedik, E, Chew, P., and Walsh, J. H. (1997). Somatostatin inhibits gastrin release and acid secretion by activating sst2 in dogs. Am. J. Physiol. 272, G1481-G1488.
76. Lu, X., Zhao, X., Feng, J., Liou, A. P., Anthony, S., Pechhold, S., et al. (2012). Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid (LCFA) through GPR 120 in isolated gastric ghrelin cells and mice. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G367-G376.
77. Ludvigsen, E., Olsson, R., Stridsberg, M., Janson, E. T., and Sandler, S. (2004). Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats. J. Histochem. Cytochem. 52,391-400.
78. Luque, R. M., Gahete, M. D., Hochgeschwender, U., and Kineman, R. D. (2006a). Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways. Am. J. Physiol. Endocrinol. Metab. 291,E395-E403.
79. Luque, R. M., Peinado, J. R., Gracia-Navarro, F., Broglio, F., Ghigo, E., Kineman, R. D., et al. (2006b). Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in soma-totropes. J. Mol. Endocrinol. 36, 547-556.
80. Malagon, M. M., Luque, R. M., Ruiz-Guerrero, E., Rodriguez-Pacheco, F., Garcia-Navarro, S., Casanueva, E E, et al. (2003). Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 144, 5372-5380.
81. Marco, J., Correas, I., Zulueta, M. A., Vincent, E., Coy, D. H., Comaru-Schally, A. M., et al. (1983). Inhibitory effect of somatostatin-28 on pancreatic polypeptide, glucagon and insulin secretion in normal man. Horm. Metab. Res. 15, 363-366.
82. Martinez, V., Rivier, J., Coy, D., and Taché, Y. (2000). Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. J. Pharmacol. Exp. Ther. 293, 1099-1105.
83. Moga, M. M., and Gray, T. S. (1985). Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J. Comp. Neu-rol. 241,275-284.
84. Mönnikes, H., Raybould, H. E., Schmidt, B., and Taché, Y. (1993). CRF in the paraventricular nucleus of the hypothalamus stimulates colonic motor activity in fasted rats. Peptides 14, 743-747.
85. Mönnikes, H., Schmidt, B. G., Tebbe, J., Bauer, C., and Taché, Y. (1994). Microinfusion of corti-cotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats. Brain Res. 644, 101-108.
86. Mori, K., Kim, J., and Sasaki, K. (2010). Electrophysiological effect of ghrelin and somatostatin on rat hypothala-mic arcuate neurons in vitro. Peptides 31, 1139-1145.
87. Muccioli, G., Papotti, M., Locatelli, V., Ghigo, E., and Deghenghi, R. (2001). Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J. Endocrinol. Invest. 24, RC7-RC9.
88. Nishi, Y., Hiejima, H., Hosoda, H., Kaiya, H., Mori, K., Fukue, Y., et al. (2005). Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 146, 2255-2264.
89. Norrelund, H., Hansen, T. K., Orskov, H., Hosoda, H., Kojima, M., Kangawa, K., et al. (2002). Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin. Endocrinol. (Oxf) 57, 539-546.
90. Pan, W., Tu, H., and Kastin, A. J. (2006). Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 27, 911-916.
91. Papotti, M., Cassoni, P., Volante, M., Deghenghi, R., Muccioli, G., and Ghigo, E. (2001). Ghrelin-producing endocrine tumors of the stomach, and intestine. J. Clin. Endocrinol. Metab. 86, 5052-5059.
92. Papotti, M., Tarabra, E., Allia, E., Bozzalla-Cassione, F., Broglio, F., Deghenghi, R., et al. (2003). Presence of cortistatin in the human pancreas. J. Endocrinol. Invest. 26, RC15-RC18.
93. Pavel, M. E., and Wiedenmann, B. (2011). Novel therapeutic agents for the treatment of gastroenteropancre-atic neuroendocrine tumors. Horm. Metab. Res. 43, 844-853.
94. Pederson, R. A., Dryburgh, J. R., and Brown, J. C. (1975). The effect of somatostatin on release and insulinotropic action of gastric inhibitory polypeptide. Can. J. Physiol. Pharmacol. 53, 1200-1205.
95. Pfluger, P. T., Kirchner, H., Gunnel, S., Schrott, B., Perez-Tilve, D., Fu, S., et al. (2008). Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G610-G618.
96. Piqueras, L., Taché, Y., and Martinez, V. (2003). Somatostatin receptor type 2 mediates bombesin-induced inhibition of gastric acid secretion in mice. J. Physiol. 549, 889-901.
97. Pradayrol, L., Jornvall, H., Mutt, V., and Ribet, A. (1980). N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett. 109, 55-58.
98. Prodam, F., Benso, A., Gramaglia, E., Lucatello, B., Riganti, F., van der Lely, A. J., et al. (2008). Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans. Neu-ropeptides 42, 89-93.
99. Raffel, A., Krausch, M., Cupisti, K., Gerharz, C. D., Eisenberger, C. F., and Knoefel, W. T. (2005). Ghrelin expression in neuroendocrine tumours of the gastrointestinal tract with multiple endocrine neoplasia type 1. Horm. Metab. Res. 37, 653-655.
100. Redding, T.W., and Schally, A. V. (1984). Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. Proc. Natl. Acad. Sci. U.S.A. 81, 248-252.
101. Reichlin, S. (1983). Somatostatin. N. Engl. J. Med. 309, 1495-1501.
102. Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., and Patel, Y C. (2000). Subtypes of the somatostatin receptor assemble as functional homo and heterodimers. J. Biol. Chem. 275, 7862-7869.
103. Rodriguez, A., Gomez-Ambrosi, J., Catalan, V., Rotellar, F., Valenti, V., Silva, C., et al. (2012). The ghrelin O-acyltransferase-ghrelin system reduces TNF-alpha-induced apopto-sis and autophagy in human visceral adipocytes. Diabetologia 55, 3038- 3050.
104. Rokaeus, A. (1984). Increase in neurotensin-like immunoreactivity in rat plasma after administration of calcium, bombesin and fat and its inhibition by somatostatin. Acta Physiol. Scand. 122, 261-267.
105. Rong, W., Winchester, W. J., and Grundy, D. (2007). Spontaneous hypersensitivity in mesenteric afferent nerves of mice deficient in the sst2 subtype of somatostatin receptor. J. Physiol. 581,779-786.
106. Saegusa, Y., Takeda, H., Muto, S., Nak-agawa, K., Ohnishi, S., Sadakane, C., et al. (2011). Decreased plasma ghrelin contributes to anorexia following novelty stress. Am. J. Physiol. Endocrinol. Metab. 301, E685-E696.
107. Sakata, I., Yamazaki, M., Inoue, K., Hayashi, Y., Kangawa, K., and Sakai, T. (2003). Growth hormone secre-tagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci. Lett. 342,183-186.
108. Sakata, I., Yang, J., Lee, C. E., Osborne-Lawrence, S., Rovinsky, S. A., Elmquist, J. K., et al. (2009). Colocal-ization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. Am. J. Physiol. Endocrinol. Metab. 297,E134-E141.
109. Salome, N., Haage, D., Perrissoud, D., Moulin, A., Demange, L., Egecioglu, E., et al. (2009). Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats. Eur. J. Pharmacol. 612, 167-173.
110. Saveanu, A., Gunz, G., Dufour, H., Caron, P., Fina, F., Ouafik, L., et al. (2001). Bim-23244, a somatostatin receptor subtype 2 and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. J. Clin. Endocrinol. Metab. 86, 140-145.
111. Schafer, J., and Meyerhof, W. (1999). sst1 mRNA is the prominent somatostatin receptor mRNA in the rat gastrointestinal tract: reverse transcription polymerase chain reaction and in situ-hybridization study. Neu-ropeptides 33, 457-463.
112. Schulz, S., Handel, M., Schreff, M., Schmidt, H., and Hollt, V. (2000). Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J. Physiol. Paris 94, 259-264.
113. Schwetz, I., Naliboff, B., Munakata, J., Lembo, T., Chang, L., Matin, K., et al. (2004). Anti-hyperalgesic effect of octreotide in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 19, 123-131.
114. Sekino, A., Ohata, H., Mano-Otagiri, A., Arai, K., and Shibasaki, T. (2004). Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats. Psychopharma-cology (Berl.) 76, 30-38.
115. Seoane, L. M., Al-Massadi, O., Bar-reiro, F., Dieguez, C., and Casanueva, F. F. (2007). Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system. J. Endocrinol. Invest. 30, RC22-RC25.
116. Sheriff, S., Kadeer, N., Joshi, R., Friend, L. A., James, J. H., and Balasubra-maniam, A. (2012). Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats. Mol. Cell. Endocrinol. 351, 286-295.
117. Shimada, M., Date, Y., Mondal, M. S., Toshinai, K., Shimbara, T., Fuku-naga, K., et al. (2003). Somatostatin suppresses ghrelin secretion from the rat stomach. Biochem. Biophys. Res. Commun. 302, 520-525.
118. Shimon, I., Taylor, J. E., Dong, J. Z., Bitonte, R. A., Kim, S., Morgan, B., et al. (1997). Somatostatin receptor subtype specificity in human fet al pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J. Clin. Invest. 99, 789-798.
119. Shiratori, K., Watanabe, S., and Takeuchi, T. (1991). Somatostatin analog, SMS 201-995, inhibits pancreatic exocrine secretion and release of secretin and cholecystokinin in rats. Pancreas 6, 23-30.
120. Sibilia, V., Pagani, F., Mrak, E., Dieci, E., Tulipano, G., and Ferrucci, F. (2012). Pharmacological characterization of the ghrelin receptor mediating its inhibitory action on inflammatory pain in rats. Amino Acids 43, 1751-1759.
121. Siehler, S., Nunn, C., Hannon, J., Feuer-bach, D., and Hoyer, D. (2008). Pharmacological profile of somatostatin and cortistatin receptors. Mol. Cell. Endocrinol. 286, 26-34.
122. Silva, A. P., Bethmann, K., Raulf, F., andSchmid,H.A. (2005). Regulation of ghrelin secretion by somatostatin analogs in rats. Eur. J. Endocrinol. 152, 887-894.
123. Smedh, U., Kaplan, J. M., Bjork-strand, E., and Uvnas-Moberg, K. (1999). Dual effects of somatostatin analog octreotide on gastric emptying during and after intragastric fill. Am. J. Physiol. 277, R1291-R1296.
124. Spary, E. J., Maqbool, A., and Batten, T. F. (2008). Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation. J. Chem. Neuroanat. 35, 49-66.
125. Spier, A. D., and de Lecea, L. (2000). Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res. Brain Res. Rev. 33,228-241.
126. Stengel, A., Coskun, T., Goebel, M., Wang, L., Craft, L., Alsina-Fernandez, J., et al. (2010a). Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats. Endocrinology 151,4224-4235.
127. Stengel, A., Goebel, M., Luckey, A., Yuan, P. Q., Wang, L., and Taché, Y. (2010b). Cold ambient temperature reverses abdominal surgery-induced delayed gastric emptying, and decreased plasma ghrelin levels in rats. Peptides 31, 2229-2235.
128. Stengel, A., Goebel, M., Wang, L., Riv-ier, J., Kobelt, P., Mönnikes, H., et al. (2010c). Activation of brain somato-statin(2) receptors stimulates feeding in mice: analysis of food intake microstructure. Physiol. Behav. 101, 614-622.
129. Stengel, A., Goebel, M., Wang, L., Riv-ier, J., Kobelt, P., Mönnikes, H., et al. (2010d). Selective central activation of somatostatin2 receptor increases food intake, grooming behavior and rectal temperature in rats. J. Physiol. Pharmacol. 61, 399-407.
130. Stengel, A., Goebel, M., Wang, L., and Taché, Y (2010e). Ghrelin, des-acyl ghrelin, and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight. Peptides 31, 357-369.
131. Stengel, A., Goebel, M., Wang, L., Taché, Y., Sachs, G., and Lambrecht, N. W (2010f). Differential distribution of ghrelin-O-acyltransferase (GOAT) immunoreactive cells in the mouse and rat gastric oxyntic mucosa. Biochem. Biophys. Res. Commun. 392,67-71.
132. Stengel, A., Goebel-Stengel, M., Wang, L., Larauche, M., Rivier, J., and Taché, Y (2011a). Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric, and colonic motor function in mice. Neurogastroenterol. Motil. 23, e223-e236.
133. Stengel, A., Goebel-Stengel, M., Wang, L., Luckey, A., Hu, E., Rivier, J., et al. (2011b). Central administration of pan-somatostatin agonist ODT8-SST prevents abdominal surgery-induced inhibition of circulating ghrelin, food intake and gastric emptying in rats. Neurogastroenterol. Motil. 23, e294-e308.
134. Stengel, A., Goebel-Stengel, M., Wang, L., Shaikh, A., Lambrecht, N. W., Rivier, J. E., et al. (2011c). Abdominal surgery inhibits circulating acyl ghrelin, and ghrelin-O-acyltransferase levels in rats: role of the somatostatin receptor subtype 2. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G239-G248.
135. Stengel, A., Keire, D., Goebel, M., Evile-vitch, L., Wiggins, B., Taché, Y., et al. (2009). The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 150, 5113-5118.
136. Sternini, C., Wong, H., Wu, S. V., de Giorgio, R., Yang, M., Reeve, J. Jr., et al. (1997). Somatostatin 2A receptor is expressed by enteric neurons, and by interstitial cells of Cajal and enterochromaffin-like cells of the gastrointestinal tract. J. Comp. Neu-rol. 386, 396-408.
137. Strassburg, S., Anker, S., Castaneda, T., Burget, L., Perez-Tilve, D., Pfluger, P. T., et al. (2008). Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am. J. Physiol. Endocrinol. Metab. 295, E78-E84.
138. Strowski, M. Z., Parmar, R. M., Blake, A. D., and Schaeffer, J. M. (2000). Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 141, 111-117.
139. Sun, Y., Ahmed, S., and Smith, R. G. (2003). Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 23, 7973-7981.
140. Sun, Y., Wang, P., Zheng, H., and Smith, R. G. (2004). Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U.S.A. 101, 4679-4684.
141. Suzuki, K., Jayasena, C. N., and Bloom, S. R. (2011). The gut hormones in appetite regulation. J. Obes. 2011, 528401.
142. Taal, B. G., and Visser, O. (2004). Epidemiology of neuroendocrine tumours. Neuroendocrinology 80 (Suppl. 1), 3-7.
143. Taché, Y., and Bonaz, B. (2007). Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J. Clin. Invest. 117,33-40.
144. Tang-Christensen, M., Vrang, N., Ort-mann, S., Bidlingmaier, M., Horvath, T. L., and Tschöp, M. (2004). Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 45, 4645-4652.
145. Tansy, M. F., Martin, J. S., Landin, W. E., and Kendall, F. M. (1979). Species difference in GI motor response to somatostatin. J. Pharm. Sci. 68,1107- 1113.
146. Tebbe, J. J., Pasat, I. R., Mönnikes, H., Ritter, M., Kobelt, P., and Schafer, M. K. (2005). Excitatory stimulation of neurons in the arcuate nucleus initiates central CRF-dependent stimulation of colonic propulsion in rats. Brain Res. 1036,130-138.
147. Thoss, V. S., Perez, J., Duc, D., and Hoyer, D. (1995). Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34, 1673-1688.
148. Tizabi, Y., and Calogero, A. E. (1992). Effect of various neurotransmitters and neuropeptides on the release of corticotropin-releasing hormone from the rat cortex in vitro. Synapse 10,341-348.
149. Toshinai, K., Mondal, M. S., Nakazato, M., Date, Y., Murakami, N., Kojima, M., et al. (2001). Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypo-glycemia, and leptin administration. Biochem. Biophys. Res. Commun. 281, 1220-1225.
150. Tringali, G., Greco, M. C., Lisi, L., Pozzoli, G., and Navarra, P. (2012). Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. Peptides 34, 353-359.
151. Tschöp, M., Smiley, D. L., and Heiman, M. L. (2000). Ghrelin induces adiposity in rodents. Nature 407, 908-913.
152. Tschöp, M., Wawarta, R., Riepl, R. L., Friedrich, S., Bidlingmaier, M., Land-graf, R., et al. (2001a). Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol Invest. 24, RC19-RC21.
153. Tschöp, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E., and Heiman, M. L. (2001b). Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707-709.
154. Tsolakis, A. V., Portela-Gomes, G. M., Stridsberg, M., Grimelius, L., Sundin, A., Eriksson, B. K., et al. (2004). Malignant gastric ghreli-noma with hyperghrelinemia. J. Clin. Endocrinol. Metab. 89, 3739-3744.
155. Uhl, G. R., Tran, V., Snyder, S. H., and Martin, J. B. (1985). Somatostatin receptors: distribution in rat central nervous system and human frontal cortex. J. Comp. Neurol. 240, 288-304.
156. van der Hoek, J., Lamberts, S. W., and Hofland, L. J. (2010). The somatostatin receptor subtype 5 in neu-roendocrine tumours. Expert Opin. Investig. Drugs 19, 385-399.
157. Veldhuis, J. D., Iranmanesh, A., Mielke, K., Miles, J. M., Carpenter, P. C., and Bowers, C. Y. (2006). Ghrelin potentiates growth hormone secretion driven by putative somatostatin withdrawal and resists inhibition by human corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 91, 2441-2446.
158. Viollet, C., Prevost, G., Maubert, E., Faivre-Bauman, A., Gardette, R., Kor-don, C., et al. (1995). Molecular pharmacology of somatostatin receptors. Fundam. Clin. Pharmacol. 9, 107-113.
159. Viollet, C., Vaillend, C., Videau, C., Bluet-Pajot, M. T., Ungerer, A., L'Heritier, A., et al. (2000). Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice. Eur. J. Neurosci. 12,3761-3770.
160. Volante, M., Allia, E., Gugliotta, P., Funaro, A., Broglio, F., Deghenghi, R., et al. (2002). Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 87, 1300-1308.
161. Walsh, J. (1994). "Somatostatin," in Physiology of the Gastrointestinal Tract, ed. L. R. Johnson (New York: Raven Press), 31-48.
162. Wang, L., Goebel-Stengel, M., Stengel, A., Wu, S. V., Ohning, G., and Taché, Y. (2011). Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery. Brain Res. 1415, 34-46.
163. Wren, A. M., Small, C. J., Ward, H. L., Murphy, K. G., Dakin, C. L., Taheri, S., et al. (2000). The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325-4328.
164. Xidakis, C., Mastrodimou, N., Notas, G., Renieri, E., Kolios, G., Kouroumalis, E., et al. (2007). RT-PCR and immunocytochem-istry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells. Regul. Pept. 143, 76-82.
165. Xu, G., Li, Y., An, W., Li, S., Guan, Y., Wang, N., et al. (2009). Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake. Endocrinology 150, 3637-3644.
166. Yakabi, K., Noguchi, M., Ohno, S., Ro, S., Onouchi, T., Ochiai, M., et al. (2011). Urocortin 1 reduces foo d intake and ghrelin secretion via CRF(2) receptors. Am. J. Physiol. Endocrinol. Metab. 301, E72-E82.
167. Yamazaki, M., Nakamura, K., Kobayashi, H., Matsubara, M., Hayashi, Y., Kangawa, K., et al. (2002). Regulational effect of ghrelin on growth hormone secretion from perfused rat anterior pituitary cells. J. Neuro endocrinol. 14, 156-162.
168. Yang, H., Wong, H., Wu, V., Walsh, J. H., and Taché, Y. (1990). Somatostatin monoclonal antibody immunoneu-tralization increases gastrin and gastric acid secretion in urethane-anesthetized rats. Gastroenterology 99,659-665.
169. Yang, J., Brown, M. S., Liang, G., Grishin, N. V., and Goldstein, J. L. (2008). Identification of the acyl-transferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387-396.
170. Zigman, J. M., Nakano, Y., Coppari, R., Balthasar, N., Marcus, J. N., Lee, C. E., et al. (2005). Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 115,3564-3572.